BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 38360994)

  • 1. PARG-deficient tumor cells have an increased dependence on EXO1/FEN1-mediated DNA repair.
    Andronikou C; Burdova K; Dibitetto D; Lieftink C; Malzer E; Kuiken HJ; Gogola E; Ray Chaudhuri A; Beijersbergen RL; Hanzlikova H; Jonkers J; Rottenberg S
    EMBO J; 2024 Mar; 43(6):1015-1042. PubMed ID: 38360994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic Screens Reveal FEN1 and APEX2 as BRCA2 Synthetic Lethal Targets.
    Mengwasser KE; Adeyemi RO; Leng Y; Choi MY; Clairmont C; D'Andrea AD; Elledge SJ
    Mol Cell; 2019 Mar; 73(5):885-899.e6. PubMed ID: 30686591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of poly(ADP-ribose) glycohydrolase (PARG) specifically kills BRCA2-deficient tumor cells.
    Fathers C; Drayton RM; Solovieva S; Bryant HE
    Cell Cycle; 2012 Mar; 11(5):990-7. PubMed ID: 22333589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specific killing of DNA damage-response deficient cells with inhibitors of poly(ADP-ribose) glycohydrolase.
    Gravells P; Grant E; Smith KM; James DI; Bryant HE
    DNA Repair (Amst); 2017 Apr; 52():81-91. PubMed ID: 28254358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective Loss of PARG Restores PARylation and Counteracts PARP Inhibitor-Mediated Synthetic Lethality.
    Gogola E; Duarte AA; de Ruiter JR; Wiegant WW; Schmid JA; de Bruijn R; James DI; Guerrero Llobet S; Vis DJ; Annunziato S; van den Broek B; Barazas M; Kersbergen A; van de Ven M; Tarsounas M; Ogilvie DJ; van Vugt M; Wessels LFA; Bartkova J; Gromova I; Andújar-Sánchez M; Bartek J; Lopes M; van Attikum H; Borst P; Jonkers J; Rottenberg S
    Cancer Cell; 2018 Jun; 33(6):1078-1093.e12. PubMed ID: 29894693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EXO1 protects BRCA1-deficient cells against toxic DNA lesions.
    van de Kooij B; Schreuder A; Pavani R; Garzero V; Uruci S; Wendel TJ; van Hoeck A; San Martin Alonso M; Everts M; Koerse D; Callen E; Boom J; Mei H; Cuppen E; Luijsterburg MS; van Vugt MATM; Nussenzweig A; van Attikum H; Noordermeer SM
    Mol Cell; 2024 Feb; 84(4):659-674.e7. PubMed ID: 38266640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sulfoquinovosyl acylpropanediol (SQAP): Inhibition of poly(ADP-ribose) metabolism and enhanced cytotoxicity in homologous recombination repair-deficient Chinese hamster-derived cells.
    Maeda J; Shellenberger KD; Kurihara W; Haga T; Kato TA
    Mutat Res Genet Toxicol Environ Mutagen; 2023; 892():503703. PubMed ID: 37973295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Small molecule inhibitors uncover synthetic genetic interactions of human flap endonuclease 1 (FEN1) with DNA damage response genes.
    Ward TA; McHugh PJ; Durant ST
    PLoS One; 2017; 12(6):e0179278. PubMed ID: 28628639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FEN1 endonuclease as a therapeutic target for human cancers with defects in homologous recombination.
    Guo E; Ishii Y; Mueller J; Srivatsan A; Gahman T; Putnam CD; Wang JYJ; Kolodner RD
    Proc Natl Acad Sci U S A; 2020 Aug; 117(32):19415-19424. PubMed ID: 32719125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting poly(ADP-ribose) glycohydrolase to draw apoptosis codes in cancer.
    Tanuma SI; Shibui Y; Oyama T; Uchiumi F; Abe H
    Biochem Pharmacol; 2019 Sep; 167():163-172. PubMed ID: 31176615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Posttranscriptional Regulation of
    Chand SN; Zarei M; Schiewer MJ; Kamath AR; Romeo C; Lal S; Cozzitorto JA; Nevler A; Scolaro L; Londin E; Jiang W; Meisner-Kober N; Pishvaian MJ; Knudsen KE; Yeo CJ; Pascal JM; Winter JM; Brody JR
    Cancer Res; 2017 Sep; 77(18):5011-5025. PubMed ID: 28687616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deletion of the nuclear isoform of poly(ADP-ribose) glycohydrolase (PARG) reveals its function in DNA repair, genomic stability and tumorigenesis.
    Min W; Cortes U; Herceg Z; Tong WM; Wang ZQ
    Carcinogenesis; 2010 Dec; 31(12):2058-65. PubMed ID: 20926829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Poly(ADP-ribose)-binding promotes Exo1 damage recruitment and suppresses its nuclease activities.
    Cheruiyot A; Paudyal SC; Kim IK; Sparks M; Ellenberger T; Piwnica-Worms H; You Z
    DNA Repair (Amst); 2015 Nov; 35():106-15. PubMed ID: 26519824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PARG Inhibitors and Functional PARG Inhibition Models.
    Sasaki Y; Hozumi M; Fujimori H; Murakami Y; Koizumi F; Inoue K; Masutani M
    Curr Protein Pept Sci; 2016; 17(7):641-653. PubMed ID: 27817742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Poly(ADP-Ribose) Glycohydrolase (PARG) vs. Poly(ADP-Ribose) Polymerase (PARP) - Function in Genome Maintenance and Relevance of Inhibitors for Anti-cancer Therapy.
    Harrision D; Gravells P; Thompson R; Bryant HE
    Front Mol Biosci; 2020; 7():191. PubMed ID: 33005627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PCAF-Mediated Histone Acetylation Promotes Replication Fork Degradation by MRE11 and EXO1 in BRCA-Deficient Cells.
    Kim JJ; Lee SY; Choi JH; Woo HG; Xhemalce B; Miller KM
    Mol Cell; 2020 Oct; 80(2):327-344.e8. PubMed ID: 32966758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parg deficiency confers radio-sensitization through enhanced cell death in mouse ES cells exposed to various forms of ionizing radiation.
    Shirai H; Fujimori H; Gunji A; Maeda D; Hirai T; Poetsch AR; Harada H; Yoshida T; Sasai K; Okayasu R; Masutani M
    Biochem Biophys Res Commun; 2013 May; 435(1):100-6. PubMed ID: 23624507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of regulators of poly-ADP-ribose polymerase inhibitor response through complementary CRISPR knockout and activation screens.
    Clements KE; Schleicher EM; Thakar T; Hale A; Dhoonmoon A; Tolman NJ; Sharma A; Liang X; Imamura Kawasawa Y; Nicolae CM; Wang HG; De S; Moldovan GL
    Nat Commun; 2020 Nov; 11(1):6118. PubMed ID: 33257658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor progression in Apc(1638N) mice with Exo1 and Fen1 deficiencies.
    Kucherlapati M; Nguyen A; Kuraguchi M; Yang K; Fan K; Bronson R; Wei K; Lipkin M; Edelmann W; Kucherlapati R
    Oncogene; 2007 Sep; 26(43):6297-306. PubMed ID: 17452984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Silencing of poly(ADP-ribose) glycohydrolase sensitizes lung cancer cells to radiation through the abrogation of DNA damage checkpoint.
    Nakadate Y; Kodera Y; Kitamura Y; Tachibana T; Tamura T; Koizumi F
    Biochem Biophys Res Commun; 2013 Nov; 441(4):793-8. PubMed ID: 24211580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.